Fresenius Medical Care Ag ADR
(FMS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,611,120 | 2,628,501 | 1,757,090 | 1,548,851 | 1,313,149 |
| Depreciation Amortization | 1,784,339 | 856,044 | 831,312 | 775,945 | 717,322 |
| Income taxes - deferred | 71,978 | 105,311 | -229,503 | -5,628 | -45,452 |
| Accounts receivable | -71,804 | -201,349 | -97,485 | -321,734 | -331,260 |
| Accounts payable and accrued liabilities | -40,164 | 5,291 | -124,757 | 133,653 | 27,208 |
| Other Working Capital | -13,941 | 543,867 | 1,367,497 | -148,537 | -17,201 |
| Other Operating Activity | -466,543 | -1,502,549 | -1,026,750 | 157,332 | 296,281 |
| Operating Cash Flow | $2,874,985 | $2,435,117 | $2,477,404 | $2,139,882 | $1,960,047 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,246,847 | -1,184,244 | -950,848 | -1,012,330 | -935,535 |
| Net Acquisitions | -2,433,459 | 894,853 | -169,891 | -366,997 | -65,150 |
| Other Investing Activity | 1 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-3,680,305 | $-289,391 | $-1,120,739 | $-1,379,327 | $-1,000,685 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,140,842 | 1,025,439 | 639,835 | 1,028,854 | 346,330 |
| Debt Issued | 3,876,102 | 723,230 | 658,186 | 2,292 | 6,035 |
| Debt Repayment | -2,483,046 | -1,270,997 | -1,242,572 | -732,874 | -324,855 |
| Common Stock Issued | 17,768 | 55,984 | 53,792 | 49,065 | 94,166 |
| Common Stock Repurchased | -671,772 | -43,958 | -65,487 | N/A | N/A |
| Dividend Paid | -728,901 | -383,634 | -332,278 | -277,176 | -263,244 |
| Other Financing Activity | -1,673,623 | -911,195 | -614,167 | -654,922 | -865,971 |
| Financing Cash Flow | $-522,629 | $-805,130 | $-902,692 | $-584,761 | $-1,007,539 |
| Exchange Rate Effect | 53,491 | 38,249 | -149,666 | 21,939 | -36,178 |
| Beginning Cash Position | 2,403,108 | 1,155,147 | 801,249 | 549,500 | 633,855 |
| End Cash Position | 1,128,650 | 2,533,991 | 1,105,557 | 747,233 | 549,500 |
| Net Cash Flow | $-1,274,458 | $1,378,845 | $304,307 | $197,733 | $-84,355 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,874,985 | 2,435,117 | 2,477,404 | 2,139,882 | 1,960,047 |
| Capital Expenditure | -1,259,766 | -1,248,643 | -1,067,523 | -1,029,992 | -952,943 |
| Free Cash Flow | 1,615,219 | 1,186,474 | 1,409,881 | 1,109,890 | 1,007,104 |